Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

1.8%

1 terminated/withdrawn out of 55 trials

Success Rate

97.3%

+10.8% vs industry average

Late-Stage Pipeline

20%

11 trials in Phase 3/4

Results Transparency

8%

3 of 36 completed trials have results

Key Signals

3 recruiting3 with results

Enrollment Performance

Analytics

N/A
29(65.9%)
Phase 4
8(18.2%)
Phase 2
3(6.8%)
Phase 3
3(6.8%)
Early Phase 1
1(2.3%)
44Total
N/A(29)
Phase 4(8)
Phase 2(3)
Phase 3(3)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (55)

Showing 20 of 55 trials
NCT05860556Completed

Sustainable Eating Pattern to Limit Malnutrition in Older Adults

Role: collaborator

NCT05853874Not ApplicableWithdrawn

Development of Sustainable Eating Pattern to Limit Malnutrition in Older Adults

Role: collaborator

NCT07065799Not ApplicableRecruiting

Respiratory Strategies in COPD Patients With Persistent Hypercapnia Following Exacerbation

Role: collaborator

NCT04102774Not ApplicableCompleted

Effect of AIRVO Heated Humidification in Bronchiectasis

Role: collaborator

NCT06162091Recruiting

Modeling Outcome in Patients With Acquired Brain Injuries

Role: collaborator

NCT03359538Phase 2Completed

Rapamycin Treatment for ALS

Role: collaborator

NCT06080607Recruiting

PRO Survivorship Concerns ITA

Role: collaborator

NCT05842577Not ApplicableCompleted

RCT on Telerehabilitation Efficacy in Parkinson's Disease

Role: collaborator

NCT01343459Not ApplicableCompleted

Intra-Operative Electron Boost and Hypofractionated Whole-Breast Irradiation During Breast-conserving Treatment (BCT)

Role: collaborator

NCT02522637Not ApplicableCompleted

Exercise Training in Severe COPD

Role: lead

NCT01556139Not ApplicableCompleted

Effectiveness of Respiratory Muscle Training by Spirotiger in Chronic Patients

Role: lead

NCT05188690Unknown

Polyneuropathy and COVID-19

Role: collaborator

NCT04875949Not ApplicableCompleted

Anti-Cholinergic Receptors Antibodies, Autonomic Profile and Dysautonomia Symptoms in PAF, ALS and POTS (DISAUT-AB)

Role: collaborator

NCT03018535Phase 3Unknown

Rituximab Versus Steroids and Cyclophosphamide in the Treatment of Idiopathic Membranous Nephropathy

Role: collaborator

NCT03821285Not ApplicableUnknown

Respiratory Function in Patients With Post-tuberculosis Lung Impairment

Role: collaborator

NCT03758547Not ApplicableUnknown

Effects of Secretion Removal in Ventilated Patients

Role: collaborator

NCT03042806Not ApplicableUnknown

Validation of a Questionnaire for Physical Activity in COPD: Maugeri Physical Activity Questionnaire (MaPAct)

Role: collaborator

NCT02537132Not ApplicableCompleted

"New Perspectives of Adaptation to NIV in ALS"

Role: collaborator

NCT02547532Completed

Microbioma in Sputa From COPD With Alpha-1 Antitrypsin Deficiency

Role: lead

NCT02499796Not ApplicableCompleted

Short-term Effects of Humidification Devices on Respiratory Pattern and Work of Breathing During Invasive Ventilation

Role: lead